Clinical Trial Update: Interferon-Beta Gene Transfer (Ad.hIFN-β) as Treatment for Refractory Colorectal Carcinoma With Liver Metastases [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial of Ad.hIFN-β (interferon-beta gene transfer) by Biogen for refractory metastatic colorectal cancer with liver metastases has complete…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Ad.hIFN-β (interferon-beta gene transfer)

Snippet

Sponsor: Biogen | Conditions: Colorectal Carcinoma, Metastases | Phase 1, Phase 2 | Status: COMPLETED